{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:40:33Z","timestamp":1792525233344,"version":"4.5.0"},"reference-count":5,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,1]]},"DOI":"10.2337\/dc26-0678","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:02:01Z","timestamp":1792522921000},"page":"e210-e210","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Oral Semaglutide and the Kidney: Promise, Limitations, and the Road Ahead"],"prefix":"10.2337","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9941-0605","authenticated-orcid":false,"given":"Wenlu","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Nephrology, Traditional Chinese Medicine Northern Hospital , Baotou, Inner Mongolia, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Traditional Chinese Medicine Northern Hospital , Baotou, Inner Mongolia, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Traditional Chinese Medicine Northern Hospital , Baotou, Inner Mongolia, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"2026102015015605800_B1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/dc25-1080","article-title":"Impact of oral semaglutide on kidney outcomes in people with type 2 diabetes: results from the SOUL randomized trial","volume":"49","author":"Mann","year":"2026","journal-title":"Diabetes Care"},{"key":"2026102015015605800_B2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"2026102015015605800_B3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026102015015605800_B4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026102015015605800_B5","doi-asserted-by":"crossref","first-page":"e078242","DOI":"10.1136\/bmj-2023-078242","article-title":"Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study","volume":"385","author":"Simms-Williams","year":"2024","journal-title":"BMJ"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/11\/e210\/898936\/dc260678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/11\/e210\/898936\/dc260678.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:02:02Z","timestamp":1792522922000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/11\/e210\/172773\/Oral-Semaglutide-and-the-Kidney-Promise"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":5,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,10,20]]},"published-print":{"date-parts":[[2026,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc26-0678","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]}}}